Home › Research › Biomarkers
CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study
Plantone D, Pardini M, Manco C, Righi D, Alì PA, Arnaldi D, Pelagotti V, Massa F et al.. Therapeutic advances in neurological disorders, 2025-02-19
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Despite their potential usefulness as biomarkers, no study has investigated the interactions between cerebrospinal fluid (CSF) changes of neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), growth differentiation factor 15 (GDF-15), transactive response DNA binding protein (TDP-43) and interleukin-6 (IL-6) and the core AD CSF biomarkers in the same cohort of AD patients. Objectives The aim of this pilot study is to evaluate the CSF levels of these analytes in patients with AD and assess their clinical relevance in this neurological condition. Design Cross-sectional study. Methods We assessed the levels of NfL, GFAP, GDF-15, TDP-43 and IL-6 in the CSF samples of 52 early AD patients and evaluated their partial reciprocal correlations and those with Abeta42, p-Tau, t-Tau and Mini-Mental State Examination (MMSE), always adding age, sex and educational level as covariates. Results MMSE score showed a positive correlation with the Aβ 1-42 concentrations ( r = 0.485; p r = -0.418; p = 0.002). IL-6 concentrations showed a positive correlation with NfL concentrations ( r = 0.312; p = 0.026) and a negative correlation with TDP-43 concentrations ( r = -0.322; p = 0.021). TDP-43 concentrations showed a positive correlation with GFAP ( r = 0.33, p = 0.018). The mediation analysis suggests that the association between GDF-15 and MMSE is primarily mediated by Aβ 1-42. CSF GDF-15 concentrations were higher in AD patients with low Aβ 1-42 concentrations than those with high Aβ 1-42 concentrations ( p Conclusion Our findings highlight that CSF IL-6 levels correlate positively with markers of neuronal damage. CSF TDP-43 levels significantly correlated with GFAP, suggesting a potential link with reactive gliosis and astrocyte activation. In addition, while CSF GDF-15 levels negatively correlate with MMSE scores, mediation analysis revealed that this association is primarily indirect and mediated through Aβ 1-42 levels.
What this study adds
Evidence grade: Moderate
This is a cross-sectional study. In 52 patients with early Alzheimer's disease, this pilot cross-sectional study found correlations among CSF markers such as IL-6, NfL, TDP-43, GFAP and GDF-15, with GDF-15's link to MMSE mainly mediated by Aβ 1-42. It is a small pilot biomarker study and does not test any treatment, cure or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Plantone, D., Pardini, M., Manco, C., Righi, D., Alì, P. A., Arnaldi, D., et al. (2025). CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study. Therapeutic advances in neurological disorders. https://doi.org/10.1177/17562864251314773
Vancouver
Plantone D, Pardini M, Manco C, Righi D, Alì PA, Arnaldi D, et al. CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study. Therapeutic advances in neurological disorders. 2025. doi:10.1177/17562864251314773. PMID: 39974169.
BibTeX
@article{plantone2025-39974169,
author = {Plantone, D. and Pardini, M. and Manco, C. and Righi, D. and Alì, P. A. and Arnaldi, D. and Pelagotti, V. and Massa, F. and others},
title = {{CSF IL-6, GDF-15, GFAP and NfL levels in early Alzheimer disease: a pilot study}},
journal = {Therapeutic advances in neurological disorders},
year = {2025},
doi = {10.1177/17562864251314773},
pmid = {39974169},
url = {https://doi.org/10.1177/17562864251314773}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results MMSE score showed a positive correlation with the Aβ 1-42 concentrations ( r = 0.485; p r = -0.418; p = 0.002).
- The mediation analysis suggests that the association between GDF-15 and MMSE is primarily mediated by Aβ 1-42.
- CSF GDF-15 concentrations were higher in AD patients with low Aβ 1-42 concentrations than those with high Aβ 1-42 concentrations ( p Conclusion Our findings highlight that CSF IL-6 levels correlate positively with markers of neuronal damage.
- CSF TDP-43 levels significantly correlated with GFAP, suggesting a potential link with reactive gliosis and astrocyte activation.
- In addition, while CSF GDF-15 levels negatively correlate with MMSE scores, mediation analysis revealed that this association is primarily indirect and mediated through Aβ 1-42 levels.
Why it matters
In 52 patients with early Alzheimer's disease, this pilot cross-sectional study found correlations among CSF markers such as IL-6, NfL, TDP-43, GFAP and GDF-15, with GDF-15's link to MMSE mainly mediated by Aβ 1-42. It is a small pilot biomarker study and does not test any treatment, cure or prevention.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designcross-sectional
- Evidence strengthModerate
How this study scored 47/100
Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Therapeutic advances in neurological disorders) |
| Journal's citation record | 1 / 4 | Therapeutic Advances in Neurological Disorders: journal h-index 93 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 13 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 4.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 8.3× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 13 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Nicola De Stefano: h-index 98 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Genoa: institution h-index 727 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 3 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39974169) |
| Free to read | 2 / 2 | Free to read |
| Total | 47 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1177/17562864251314773
- PubMed: 39974169
- Original source →
- Free full text: Therapeutic Advances in Neurological Disorders →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.